{
    "Trade/Device Name(s)": [
        "FastPack\u00ae Vitamin D Immunoassay",
        "FastPack\u00ae Vitamin D Calibrator Kit",
        "FastPack\u00ae Vitamin D Control Kit",
        "FastPack\u00ae Vitamin D Method Verification Kit"
    ],
    "Submitter Information": "Qualigen, Inc.",
    "510(k) Number": "K123983",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112725"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "May 31, 2013",
    "Summary Letter Received Date": "June 3, 2013",
    "Submission Date": "June 27, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1825",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Vitamin D test system",
        "Calibrator",
        "Quality control material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total 25-hydroxyvitamin D",
        "25-hydroxyvitamin D2",
        "25-hydroxyvitamin D3",
        "1,25-(OH)2-Vitamin D2",
        "1,25-(OH)2-Vitamin D3",
        "3-epi-25(OH) Vitamin D3",
        "24,25-(OH)2-Vitamin D2",
        "24,25-(OH)2-Vitamin D3",
        "Paricalcitol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (EDTA)",
        "Plasma (Lithium-heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FastPack\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive immunoassay",
        "Chemiluminescence"
    ],
    "Methodologies": [
        "Direct competitive chemiluminescence immunoassay employing paramagnetic particles"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Verification kit"
    ],
    "Document Summary": "FDA 510(k) summary for FastPack Vitamin D Immunoassay and associated calibrator, control, and method verification kits for quantitative measurement of vitamin D metabolites in human serum and plasma using chemiluminescence on the FastPack Analyzer.",
    "Indications for Use Summary": "For quantitative determination of total 25-hydroxyvitamin D and other hydroxylated metabolites in human serum and plasma to aid assessment of vitamin D sufficiency in adults; calibrator, control, and method verification kits are used for calibration, quality control, and range verification of the FastPack Vitamin D Immunoassay on the FastPack Analyzer.",
    "fda_folder": "Clinical Chemistry"
}